BGM Group Corp (BGM) - Multiplikator Forward P/S

Logo grafis BGM Group Ltd (BGM)

BGM Group Ltd (BGM) integrates AI technologies with biopharmaceuticals, actively expanding its distribution network and finalizing clinical trials. The forward P/S ratio reflects market revenue expectations, with the value holding at 1.00. High barriers to entry and the battle for patents securely protect this niche from external players, providing the company with strategic isolation.

BGM BGM Group Limited: Rega forward marang dodolan ing interval 13.08.2024 - 16.11.2026

Rincian metrik lan analitis perusahaan BGM Group (BGM)

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:bgm.ltd BGM
Sampel barang bgm.ltd

At the commercialization stage of niche generics, BGM Group Ltd (BGM) is transitioning from R&D to scaling sales, making revenue valuation a key value driver. The company's modeled P/S ratio compares current market capitalization with projected annual turnover, allowing investors to quickly determine the premium paid for the business and assess the sustainability of market expectations through the dynamics of this chart.

Pesaing utama

Rasio rega marang prakiraan pendapatan Vertex VRTX|ALNY (Alnylam Inc.) - Rega mangsa ngarep marang pendapatan|Insmed Incorporated - Multiplikator Forward P/S|Rega forward marang dodolan UTHR (United Therapeutics)|BMRN: Multiplikator Forward P/S|BridgeBio Pharma (BBIO) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Cogent Bio|XERS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan kerostx.com (KROS)|Multiplikator forward rega marang pendapatan Arcturus Therapeutics ARCT|Multiplikator Forward P/S ETON (etonpharma.com)|Multiplikator Forward P/S Kamada Ltd KMDA|Fulcrum Therapeutics, Inc. - Multiplikator Forward P/S|ABEO - Multiplikator Forward P/S|MREO: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Protalix BioTherapeutics, Inc. (PLX)|PLRX (Pliant Therapeutics, Inc.) - Multiplikator Forward P/S|Applied Therapeutics Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Rein Therapeutics Inc (RNTX)|Rasio rega marang pendapatan sing dikarepake GELS|Aytu BioPharma, Inc. - Multiplikator forward rega marang pendapatan|Chemomab Therapeutics (CMMB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SRx Health - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Polyrizon Limited PLRZ|AEZS: Multiplikator Forward P/S|CYTH: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan INZY|RPHM: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan CSCI (COSCIENS Biopharma)